Two recent studies evaluated the effects of asthma through addressing the costs and adherence to medications as well as the accessibility to certain resources for patients.
Two recent studies evaluated the effects of asthma through addressing the costs and adherence to medications as well as the accessibility to certain resources for patients.
One study assessed the patient adherence in Australia, specifically looking at the cost-related under-use of asthma medicines among adults and children. The study involved a cross-sectional population-based online survey of adults with asthma and parents of children between the ages of 5 and 17 with asthma.
The results consisted of completed surveys from 792 adults with asthma and 609 parents of children with asthma. Of the adults, 419 (52.9%) reported delaying or skipping refills/doses or taking fewer puffs in the last 12 months because of the cost, while 243 (30.7) reported foregoing basic needs in the last 12 months to pay for asthma medicines.
For the parents of children with asthma, 209 (34.3%) reported delaying or skipping doses or taking fewer puffs in the last 12 months due to the cost, and 269 (44.2%) reported foregoing basic needs in the last 12 months for asthma treatment.
Additionally, the results revealed that cost-related medicine under-use was reported lower among:
“Health professionals should be encouraged to ask patients if they have concerns about their asthma medicines including about cost; to optimize cost-effectiveness by checking inhaler technique and avoiding over-treatment; and to consider offering options with a lower overall out-of-pocket cost,” the authors concluded.
Another study investigated if an English-only patient portal of the electronic health record would benefit patients who have limited educational opportunities, resources, and access to information technology.
The study included adults with uncontrolled asthma who lived in low-income urban neighborhoods. Each patient received portal training (PT) and half were randomized to home visits (HV) by community health workers. The training included 7 tasks, such as reviewing an upcoming appointment and requesting a refill. The patients were followed for 1 year.
The results revealed fewer than 60% of patients used the portal independently—the frequeny of portal use was associated with younger age, higher reported household income, and education beyond high school. Portal use was also less likely in patients with diabetes, hypertension, or hospitalizations for asthma, but it was not linked with gender, race, ethnicity, or Spanish as a primary language.
The most frequent usage of the portal was for reading messages and getting lab results, while the least frequent usage was sending messages and making appointments.
“Patients with the most uncontrolled asthma and other medical comorbidities were least likely to use the portal,” the authors concluded. “The patient portal needs revision to accommodate patients with the highest asthma morbidity and healthcare needs.”
References
1. Reddel HK, Laba T, Jan S, et al. Effects of out-of-pocket costs on patient adherence with asthma medicines. Presented at the American Thoracic Society 2018 International Conference. May 20, 2018; San Diego, California. Abstract A1083.
2. Apter AJ, Bryant-Stephens T, Perez L, et al. Electronic health record patient portal access for low income and minority adults with uncontrolled ashtma. Presented at the American Thoracic Society 2018 International Conference. May 20, 2018; San Diego, California. Abstract A1074.
Males With Hemophilia A Report Physical, Mental Burdens of Disease Regardless of Severity
April 25th 2024Self-reported data from adult and pediatric males with hemophilia A show that burden of the disease persists regardless of severity, highlighting a need for improved prophylactic treatment.
Read More
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More